Transcode Therapeutics Inc (RNAZ)

Dec 21, 2024

Analysts Issue Forecasts for RNAZ Q1 Earnings - Defense World

Dec 21, 2024

Dec 20, 2024

TransCode Therapeutics (NASDAQ:RNAZ) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World

Dec 20, 2024

Dec 19, 2024

H.C. Wainwright raises TransCode Therapeutics target following SRC go-ahead for Cohort 3 - Investing.com

Dec 19, 2024

Dec 19, 2024

Clinical Trials News Live Feed - StockTitan

Dec 19, 2024

Dec 18, 2024

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial - StreetInsider.com

Dec 18, 2024

Dec 18, 2024

TransCode advances to third patient group in cancer trial - Investing.com India

Dec 18, 2024

Dec 18, 2024

Dow Surges 150 Points, US Current Account Deficit Widens In Q3 - Benzinga

Dec 18, 2024

Dec 18, 2024

Transcode announces SRC approved third cohort in TTX-MC138 clinical trial - TipRanks

Dec 18, 2024

Dec 18, 2024

RNAZTransCode Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Dec 18, 2024

Dec 18, 2024

TransCode's Cancer Drug TTX-MC138 Advances to Final Trial Phase with Promising Safety Data - StockTitan

Dec 18, 2024

Dec 13, 2024

Transcode Therapeutics stock hits 52-week low at $6.89 By Investing.com - Investing.com Canada

Dec 13, 2024

Dec 04, 2024

TransCode Therapeutics to execute 1-for-33 reverse stock split on Dec 4 - MSN

Dec 04, 2024

Dec 02, 2024

Janux, Vir stocks rally on positive data for Janux drug JANX007 - MSN

Dec 02, 2024

Dec 02, 2024

TransCode Therapeutics Raises $8M in Private Placement - TipRanks

Dec 02, 2024

Dec 02, 2024

Why TransCode Therapeutics (RNAZ) Stock Is Diving - Benzinga

Dec 02, 2024

Nov 30, 2024

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split - The Manila Times

Nov 30, 2024

Nov 29, 2024

TransCode Therapeutics Announces Reverse Stock Split - TipRanks

Nov 29, 2024

Nov 29, 2024

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split to Meet Nasdaq Requirements | RNAZ Stock News - StockTitan

Nov 29, 2024

Nov 28, 2024

TransCode Therapeutics announces $8M private offering - MSN

Nov 28, 2024

Nov 28, 2024

Transcode Therapeutics issues 21.2M shares at 37.7c in private placement - Yahoo Finance

Nov 28, 2024

Nov 28, 2024

TransCode secures $8 million in private placement - Investing.com India

Nov 28, 2024

Nov 27, 2024

TransCode secures $8 million in private placement By Investing.com - Investing.com Australia

Nov 27, 2024

Nov 27, 2024

TransCode Therapeutics, Inc. Announces $8 Million Private Placement - The Manila Times

Nov 27, 2024

Nov 27, 2024

TransCode Therapeutics Secures $8M Private Placement, Issues 21.2M Shares | RNAZ Stock News - StockTitan

Nov 27, 2024

Nov 26, 2024

TransCode Therapeutics, Inc. announced that it expects to receive $8 million in funding - Marketscreener.com

Nov 26, 2024

Nov 26, 2024

Transcode Therapeutics announces 1-for-33 reverse stock split - Yahoo Finance

Nov 26, 2024

Nov 26, 2024

TransCode Therapeutics approves reverse stock split By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 25, 2024

TransCode Therapeutics advances with stockholder approvals By Investing.com - Investing.com Canada

Nov 25, 2024

Nov 25, 2024

TransCode Therapeutics advances with stockholder approvals - Investing.com

Nov 25, 2024

Nov 25, 2024

TransCode Therapeutics approves reverse stock split - Investing.com

Nov 25, 2024

Nov 25, 2024

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split to Maintain Nasdaq Listing | RNAZ Stock News - StockTitan

Nov 25, 2024

Nov 21, 2024

NewAmsterdam Pharma Reports Promising Phase 3 Trial Results - Yahoo Finance

Nov 21, 2024

Nov 19, 2024

Galecto (NASDAQ:GLTO) Shares Down 5.3% – Should You Sell? - Defense World

Nov 19, 2024

Nov 19, 2024

TransCode Therapeutics (NASDAQ:RNAZ) Receives Buy Rating from HC Wainwright - Defense World

Nov 19, 2024

Nov 19, 2024

Craig Hallum Downgrades Sow Good (NASDAQ:SOWG) to Hold - Defense World

Nov 19, 2024

Nov 19, 2024

The Goldman Sachs Group Boosts Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $41.00 - Defense World

Nov 19, 2024

Nov 19, 2024

TScan Therapeutics (NASDAQ:TCRX) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 19, 2024

Nov 19, 2024

Sow Good (NASDAQ:SOWG) Lowered to Neutral Rating by Roth Mkm - Defense World

Nov 19, 2024

Nov 19, 2024

Spero Therapeutics’ (SPRO) “Overweight” Rating Reiterated at Cantor Fitzgerald - Defense World

Nov 19, 2024

Nov 15, 2024

TransCode Therapeutics Inc (RNAZ) Quarterly 10-Q Report - Quartz

Nov 15, 2024

Nov 14, 2024

Transcode Therapeutics Reports Increased Losses Amid Funding Challenges - TipRanks

Nov 14, 2024

Nov 12, 2024

Transcode Therapeutics sends open letter to shareholders - TipRanks

Nov 12, 2024

Nov 12, 2024

TransCode Therapeutics Open Letter to Shareholders - The Manila Times

Nov 12, 2024

Nov 12, 2024

TransCode (RNAZ) Faces Delisting Risk, Seeks Shareholder Approval for Reverse Split | RNAZ Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Fluor Stock Tanks on Earnings Miss. There’s Good Reason Not to Panic. - MSN

Nov 08, 2024

Nov 06, 2024

Beam stock rebounds as Leerink upgrades despite fatality in gene editing trial - MSN

Nov 06, 2024

Nov 05, 2024

TransCode Therapeutics maintains Nasdaq listing with conditions - Investing.com

Nov 05, 2024

Nov 05, 2024

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance - The Manila Times

Nov 05, 2024

Nov 05, 2024

TransCode Therapeutics maintains Nasdaq listing with conditions By Investing.com - Investing.com UK

Nov 05, 2024

Nov 05, 2024

TransCode (RNAZ) Maintains Nasdaq Listing Despite Reprimand Over Compliance Issues | RNAZ Stock News - StockTitan

Nov 05, 2024